Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Database
Language
Publication year range
1.
Biochim Biophys Acta ; 1761(7): 686-97, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16750418

ABSTRACT

1,25-Dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) and transforming growth factor beta (TGFbeta) potently induce 5-lipoxygenase (5-LO) in myeloid cells. We analyzed vitamin D receptor (VDR) binding to putative vitamin D response elements within the 5-LO promoter and analyzed its function by reporter gene analysis. Binding of VDR and retinoid X receptor to the promoter region was shown in DNase I footprinting, electrophoretic mobility shift and chromatin immunoprecipitation assays. However, the identified VDR binding region did not mediate induction of reporter gene activity by 1,25(OH)(2)D(3)/TGFbeta, neither in the 5-LO promoter context nor with the thymidine kinase (tk) promoter. Insertion of the rat atrial natriuretic factor VDRE in reporter plasmids containing the 5-LO promoter diminished induction by 1,25(OH)(2)D(3)/TGFbeta as compared with the tk promoter. Similarly, low inductions were obtained when cells were transiently or stably transfected with constructs containing various 5-LO promoter regions. Concerning basal promoter activity, we identified a positive regulatory region (-779 to -229), which includes the VDR binding region, in 5-LO-positive MonoMac6 cells. In summary, the VDR/RXR complex binds to putative VDREs in the 5-LO promoter, but other sequences outside the 5-LO promoter seem to be responsible or additionally required for the prominent induction of 5-LO mRNA expression by 1,25(OH)(2)D(3) and TGFbeta.


Subject(s)
Arachidonate 5-Lipoxygenase/genetics , Promoter Regions, Genetic , Receptors, Calcitriol/metabolism , Arachidonate 5-Lipoxygenase/metabolism , Binding Sites , Calcitriol/metabolism , Calcitriol/pharmacology , Gene Expression Regulation, Enzymologic/drug effects , Genes, Reporter , HL-60 Cells , Humans , Protein Binding , Retinoid X Receptors/metabolism , Sequence Analysis , Sequence Deletion , Transforming Growth Factor beta/pharmacology , U937 Cells
2.
Biochim Biophys Acta ; 1738(1-3): 37-47, 2005 Dec 30.
Article in English | MEDLINE | ID: mdl-16413224

ABSTRACT

5-lipoxygenase (5LO) catalyzes formation of leukotrienes, mediators with roles in several inflammatory disorders, including atherosclerosis. The human 5LO gene promoter contain multiple GC-boxes. The relevance of these for expression of 5LO in the human monocytic cell line Mono Mac 6 (MM6) was studied. A downregulating effect of the GC-box binding compound mithramycin indicated that GC-rich sequences in the 5LO gene promoter are important for expression of native 5LO. In DNase I footprinting, mithramycin and Sp1 protected known GC-boxes, but also a novel Sp1 binding site was found, comprising 20 bp upstream of the major transcription initiation site, beside an Initiator-like sequence. Mutation of this site reduced Sp1 binding and expression of reporter genes in MM6 cells, compatible with a function as basal promoter element for the TATA-less 5LO gene. When differentiation was induced by TGFbeta and vitamin D(3), 5LO expression became prominent, but expression levels of Sp1/3 and Egr-1 were the same as for control cells. Also, 5LO reporter gene activity in transiently transfected MM6 cells was insensitive to differentiation. Thus, the GC-rich part of the 5LO gene promoter, including a novel Sp1 site, appear important for basal (rather than upregulated) transcription of 5LO in MM6 cells.


Subject(s)
Arachidonate 5-Lipoxygenase/genetics , GC Rich Sequence , Monocytes/physiology , Promoter Regions, Genetic/genetics , Sp1 Transcription Factor/metabolism , Arachidonate 5-Lipoxygenase/metabolism , Binding Sites , Cell Differentiation/drug effects , Cell Differentiation/genetics , Cell Line , Early Growth Response Protein 1/genetics , Early Growth Response Protein 1/metabolism , Electrophoretic Mobility Shift Assay , Gene Expression Regulation , Gene Expression Regulation, Enzymologic/drug effects , Humans , Monocytes/cytology , Monocytes/drug effects , Plicamycin/pharmacology , Sp1 Transcription Factor/genetics , Sp3 Transcription Factor/genetics , Sp3 Transcription Factor/metabolism , Transcription Initiation Site
4.
Proc Natl Acad Sci U S A ; 99(26): 16648-53, 2002 Dec 24.
Article in English | MEDLINE | ID: mdl-12482946

ABSTRACT

RNA interference is a form of gene silencing in which the nuclease Dicer cleaves double-stranded RNA into small interfering RNAs. Here we report a role for Dicer in chromosome segregation of fission yeast. Deletion of the Dicer (dcr1+) gene caused slow growth, sensitivity to thiabendazole, lagging chromosomes during anaphase, and abrogated silencing of centromeric repeats. As Dicer in other species, Dcr1p degraded double-stranded RNA into approximately 23 nucleotide fragments in vitro, and dcr1Delta cells were partially rescued by expression of human Dicer, indicating evolutionarily conserved functions. Expression profiling demonstrated that dcr1+ was required for silencing of two genes containing a conserved motif.


Subject(s)
Chromosome Segregation/genetics , Endoribonucleases/physiology , Gene Silencing , Schizosaccharomyces/genetics , Endoribonucleases/chemistry , Endoribonucleases/genetics , Humans , Reverse Transcriptase Polymerase Chain Reaction , Ribonuclease III
5.
EMBO J ; 21(21): 5864-74, 2002 Nov 01.
Article in English | MEDLINE | ID: mdl-12411504

ABSTRACT

RNA silencing phenomena, known as post-transcriptional gene silencing in plants, quelling in fungi, and RNA interference (RNAi) in animals, are mediated by double-stranded RNA (dsRNA) and mechanistically intersect at the ribonuclease Dicer. Here, we report cloning and expression of the 218 kDa human Dicer, and characterization of its ribonuclease activity and dsRNA-binding properties. The recombinant enzyme generated approximately 21-23 nucleotide products from dsRNA. Processing of the microRNA let-7 precursor by Dicer produced an apparently mature let-7 RNA. Mg(2+) was required for dsRNase activity, but not for dsRNA binding, thereby uncoupling these reaction steps. ATP was dispensable for dsRNase activity in vitro. The Dicer.dsRNA complex formed at high KCl concentrations was catalytically inactive, suggesting that ionic interactions are involved in dsRNA cleavage. The putative dsRNA-binding domain located at the C-terminus of Dicer was demonstrated to bind dsRNA in vitro. Human Dicer expressed in mammalian cells colocalized with calreticulin, a resident protein of the endoplasmic reticulum. Availability of the recombinant Dicer protein will help improve our understanding of RNA silencing and other Dicer-related processes.


Subject(s)
Endoribonucleases/metabolism , RNA, Double-Stranded/metabolism , Ribonucleases/metabolism , Animals , Base Sequence , Cell Line , Cloning, Molecular , DNA Probes , DNA, Complementary , Electrophoretic Mobility Shift Assay , Endoplasmic Reticulum/enzymology , Endoribonucleases/genetics , Humans , Protein Binding , Recombinant Proteins/metabolism , Ribonuclease III
6.
FASEB J ; 16(11): 1441-3, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12205041

ABSTRACT

5-lipoxygenase (5-LO) is the key enzyme in the biosynthesis of proinflammatory leukotrienes. Here, we demonstrate that extracellular signal-regulated kinases (ERKs) can phosphorylate 5-LO in vitro. Efficient phosphorylation required the presence of unsaturated fatty acids and was abolished when Ser-663 was mutated to alanine. In intact HeLa cells stimulated with arachidonic acid (AA), impaired 5-LO product formation was evident in cells expressing the S663A-5-LO mutant compared with cells expressing wild-type 5-LO. For Mono Mac 6 cells, priming with phorbol myristate acetate (PMA) before stimulation with ionophore was required for ERK1/2 activation and efficient 5-LO phosphorylation, in parallel with substantial AA release and 5-LO product formation. Inhibition of PKC by GF109203x or MEK1/2 by U0126 (or PD98059) abolished the 5-LO up-regulation effects of PMA. In contrast, these inhibitors failed to suppress 5-LO product formation induced by stimuli such as AA plus ionophore, which apparently do not involve the ERK1/2 pathway. Based on inhibitor studies, ERKs are also involved in AA-stimulated 5-LO product formation in PMNL, whereas a role for ERKs is not apparent in 5-LO activation induced by ionophore or cell stress. Finally, the data suggest that ERKs and p38 MAPK-regulated MAPKAPKs can act in conjunction to stimulate 5-LO by phosphorylation.


Subject(s)
Arachidonate 5-Lipoxygenase/metabolism , Leukotrienes/biosynthesis , Mitogen-Activated Protein Kinases/physiology , Neutrophils/enzymology , Protein Kinases , Arachidonate 5-Lipoxygenase/chemistry , Cell Line , Fatty Acids, Unsaturated/pharmacology , HeLa Cells , Humans , Intracellular Signaling Peptides and Proteins , Mitogen-Activated Protein Kinase 1/physiology , Models, Biological , Neutrophils/drug effects , Neutrophils/metabolism , Phosphorylation , Protein Serine-Threonine Kinases
SELECTION OF CITATIONS
SEARCH DETAIL